Quantification of the External Validity of Randomized Controlled Trials Supporting Clinical Care Guidelines: The Case of Thromboprophylaxis

被引:0
作者
Abdallah, Sami Morin-Ben [1 ]
Dutilleul, Aurore [1 ]
Nadon, Valerie [1 ]
Yang, Ji Wei [1 ]
Marchand-Senecal, Xavier [1 ]
Nguyen, Paul Van [1 ]
Lamarre-Cliche, Maxime [1 ]
Wistaff, Robert [1 ]
Kolan, Christophe [1 ]
Laskine, Mikhael [1 ]
Durand, Madeleine [1 ]
机构
[1] Univ Montreal, Ctr Rech, Ctr Hosp, 3840 St Urbain St, Montreal, PQ H2V 3B3, Canada
关键词
American College of Chest Physicians guidelines; Exclusion criteria; External validity; Medical hospitalized patients; Padua score; Pharmacological thromboprophylaxis; Risk scores; MOLECULAR-WEIGHT HEPARIN; HOSPITALIZED MEDICAL PATIENTS; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PREVENTION; PLACEBO; PROPHYLAXIS; INPATIENTS; MORTALITY; RISK;
D O I
10.1016/j.amjmed.2016.02.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Clinical guidelines are based on the results of several randomized controlled trials. However, due to the stringent exclusion criteria of these trials, their external validity may be low. We aimed to evaluate the external validity of the randomized controlled trials cited in the American College of Chest Physicians guidelines for the use of pharmacological thromboprophylaxis in hospitalized medical patients. METHODS: We conducted a cross-sectional, chart-review study of a random sample of patients admitted between July 1, 2013 and June 30, 2014 to the Internal Medicine ward of a large Canadian teaching university hospital. We identified the proportion of our population presenting exclusion criteria used in the randomized controlled trials cited in support of clinical care guidelines on thromboprophylaxis in the medical setting. RESULTS: Nine trials were identified for a total of 28,793 included patients following 23 distinct exclusion criteria. We included 429 patients. Median age was 65 years (interquartile ratio 51-77 years), and 236 (55%) were males. Of those not already anticoagulated at admission (n = 351), between 26% and 67% (weighted average, 51%) of our population presented at least one exclusion criterion, making them ineligible to be enrolled in randomized controlled trials. When restricting our population to patients with an indication for thromboprophylaxis based on a Padua risk score at admission >= 4, 21% to 76% (weighted average 55%) were ineligible to be enrolled in individual trials. CONCLUSIONS: Our cross-sectional study illustrates that the external validity of randomized controlled trials cited in the guidelines was low in our population, and lower when applying the risk-stratification tool recommended by guidelines. This can bias the clinicians toward treating patients that were not represented in the supporting evidence. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:740 / 745
页数:6
相关论文
共 50 条
  • [31] Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines
    Mas-Llado, Caterina
    Gonzalez-Del-Hoyo, Maribel
    Siquier-Padilla, Joan
    Blaya-Pena, Laura
    Coughlan, J. J.
    de la Villa, Bernardo Garcia
    Peral, Vicente
    Rossello, Xavier
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (08) : 796 - 805
  • [32] Population Diversity Challenge the External Validity of the European Randomized Controlled Trials Comparing Laparoscopic Gastric Bypass and Sleeve Gastrectomy
    Mazzini, Guilherme S.
    Khoraki, Jad
    Browning, Matthew G.
    Pessoa, Bernardo M.
    Wolfe, Luke G.
    Campos, Guilherme M.
    OBESITY SURGERY, 2020, 30 (03) : 992 - 1000
  • [33] Population Diversity Challenge the External Validity of the European Randomized Controlled Trials Comparing Laparoscopic Gastric Bypass and Sleeve Gastrectomy
    Guilherme S. Mazzini
    Jad Khoraki
    Matthew G. Browning
    Bernardo M. Pessoa
    Luke G. Wolfe
    Guilherme M. Campos
    Obesity Surgery, 2020, 30 : 992 - 1000
  • [34] Missing links: how descriptive validity impacts the policy relevance of randomized controlled trials in criminology
    Gill, Charlotte E.
    JOURNAL OF EXPERIMENTAL CRIMINOLOGY, 2011, 7 (03) : 201 - 224
  • [35] A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
    Kennedy-Martin, Tessa
    Curtis, Sarah
    Faries, Douglas
    Robinson, Susan
    Johnston, Joseph
    TRIALS, 2015, 16
  • [36] External Validity of Randomised Controlled Trials on Carotid Revascularisation: Trial Populations May Not Always Reflect Patients in Clinical Practice
    Kallmayer, Michael A.
    Knappich, Christoph
    Karlas, Angelos
    Trenner, Matthias
    Kuehnl, Andreas
    Eckstein, Hans-Henning
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2022, 64 (05) : 452 - 460
  • [37] The effectiveness and safety of thromboprophylaxis in cancer patients based on Khorana score: a meta-analysis and systematic review of randomized controlled trials
    Bao, Y.
    Gao, B.
    Yan, P.
    Tian, L.
    Yang, K.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (11) : 1992 - 2001
  • [38] Promotoras' Roles in Integrative Validity and Treatment Fidelity Efforts in Randomized Controlled Trials
    Keller, Colleen
    Records, Kathie
    Coe, Kathryn
    Ainsworth, Barbara
    Lopez, Sonia Vega
    Nagle-Williams, Allison
    Permana, Paska
    FAMILY & COMMUNITY HEALTH, 2012, 35 (02) : 120 - 129
  • [39] A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
    Iyngkaran, Pupalan
    Toukhsati, Samia R.
    Thomas, Merlin C.
    Jelinek, Michael V.
    Hare, David L.
    Horowitz, John D.
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2016, 10 : 163 - 171
  • [40] The Fragility Index in Multicenter Randomized Controlled Critical Care Trials
    Ridgeon, Elliott E.
    Young, Paul J.
    Bellomo, Rinaldo
    Mucchetti, Marta
    Lembo, Rosalba
    Landoni, Giovanni
    CRITICAL CARE MEDICINE, 2016, 44 (07) : 1278 - 1284